How to Value a Speech Therapy Practice

Speech-language pathology practices are emerging as one of the more interesting M&A niches in healthcare services. The convergence of rising autism and developmental delay diagnoses, a severe SLP workforce shortage, expanding insurance mandates for speech therapy coverage, and growing PE interest in therapy roll-ups has created a market where well-run practices are genuinely in demand.

I've advised on speech therapy transactions that range from solo SLP practices selling for $200K to multi-location pediatric therapy groups fetching $15M+. The valuation frameworks are fundamentally different at each end of that spectrum, and understanding where your practice fits is the first step to understanding what it's worth.

Solo SLP Practice vs. Multi-Location Group: Two Different Markets

A solo speech-language pathologist who owns a practice and provides the majority of clinical hours is selling a job with a patient base attached. Buyers are typically other SLPs looking to acquire an established caseload and referral relationships rather than building from scratch. These transactions price at 2-4x SDE (seller's discretionary earnings), which accounts for the owner's clinical compensation as part of the earnings stream.

A multi-location practice with 5+ SLPs on staff, a clinical director who manages the day-to-day, and $1M+ in revenue is a different animal entirely. This is a business that can operate without the owner in the treatment room, and it attracts a completely different buyer pool — PE-backed therapy platforms, multi-discipline rehabilitation companies, and strategic acquirers building regional networks. These transactions price at 5-8x EBITDA, with the multiple driven by size, growth trajectory, and the factors I'll detail below.

The gap between these two valuations — 2-4x SDE versus 5-8x EBITDA — is one of the widest in healthcare services. If you're a solo SLP with ambitions of a premium exit, the path runs directly through building a team of clinicians who can serve patients without you.

Pediatric vs. Adult: Where the Growth Is

The single most important clinical focus question for SLP practice valuation is whether you primarily treat pediatric or adult patients. Both are viable businesses, but buyers are paying meaningfully more for pediatric-focused practices in 2026.

The reason is demographic. CDC data shows that autism spectrum disorder diagnoses have increased from 1 in 150 children in 2000 to approximately 1 in 36 in the most recent surveillance data. Developmental delay identification has followed a similar trajectory as pediatricians become better at early screening and parents become more aware. Each diagnosis generates years of speech therapy services — a child diagnosed at age 2-3 may receive speech therapy through age 8-10 or beyond.

This creates a patient base with exceptional lifetime value and high retention. Parents don't switch their child's speech therapist casually — the therapeutic relationship matters enormously for outcomes, and the switching costs are emotional as much as practical. Buyers understand this, and pediatric-focused therapy practices consistently command multiples at the top of the range.

Adult SLP practices — focused on stroke rehabilitation, traumatic brain injury, dysphagia (swallowing disorders), and voice disorders — are less in demand from acquirers primarily because the patient relationships are shorter (episode-of-care rather than multi-year) and the referral dynamics are more hospital-dependent. They're solid businesses, but the growth narrative is less compelling.

Early Intervention and School Contracts

Two contract types can dramatically affect an SLP practice's valuation: state early intervention (EI) programs and school district contracts.

Early intervention contractsare state-funded programs that provide therapy services to children ages 0-3 with developmental delays. These contracts are valuable because they're government-funded (reliable payer), create a pipeline of patients who will transition to your outpatient practice at age 3 (built-in referral source), and are difficult for new entrants to win (established providers have performance track records that state agencies weigh heavily in renewals). An SLP practice with $500K+ in annual EI contract revenue will typically see a 0.5-1.0x EBITDA premium because buyers view it as a defensible, recurring revenue stream.

School district contracts provide speech therapy services to students with IEPs (Individualized Education Programs). These contracts are typically annual, renewed through school board approval, and pay rates that are lower than private insurance but highly predictable. The volume can be substantial — a single school district contract might generate $200K-$500K annually. The risk is political: school board composition changes, budget pressures, and the occasional push to bring services in-house can create contract instability.

Buyers will evaluate your contract mix carefully. A practice with 40%+ of revenue from government contracts (EI + school districts) and 60% from private insurance and self-pay is well-diversified. A practice that's 80%+ government contract revenue carries concentration risk that compresses multiples, even though the revenue is individually predictable.

Telepractice: The Post-COVID Value Driver

COVID-19 permanently changed speech therapy delivery, and practices that embraced telepractice have a genuine competitive advantage. SLP is one of the therapy disciplines where teletherapy works particularly well — articulation exercises, language therapy, and social pragmatic interventions can all be delivered effectively through video, especially for school-age children who are comfortable with screens.

A practice with 20-30% of sessions delivered via telepractice demonstrates something buyers value enormously: geographic scalability without proportional overhead growth. You don't need to lease a new clinic space to add 50 telepractice patients from an adjacent county. The margin profile on telepractice sessions is meaningfully better than in-clinic sessions because the variable cost is essentially zero beyond the clinician's time.

Buyers also see telepractice capability as a risk mitigator. Practices that can pivot to virtual delivery have demonstrated resilience that pure brick-and-mortar operations lack. The ability to maintain caseloads during weather events, clinic closures, or future pandemic disruptions has tangible value in a buyer's risk model.

The SLP Shortage as a Competitive Moat

The American Speech-Language-Hearing Association (ASHA) reports persistent workforce shortages across most states, with demand for SLPs projected to grow faster than supply through at least 2030. This shortage is paradoxically one of the most valuable assets an SLP practice can have — if you've figured out how to recruit and retain clinicians, you possess a capability that buyers desperately need and struggle to replicate.

Practices with SLP-CCC (Certificate of Clinical Competence) holders who have been on staff for 3+ years demonstrate retention capability that is genuinely rare in this market. The credential matters because clinical fellows (SLP-CFs completing their supervised experience) cannot practice independently — a practice staffed primarily with CFs is less valuable than one staffed with experienced CCC holders because the clinical capacity is constrained by supervision requirements.

I've seen practices command 1-2x EBITDA premiums specifically because their clinician retention rates were exceptional. When a buyer can acquire an SLP practice and be reasonably confident that the clinical staff will stay, the integration risk drops dramatically. When the buyer worries that SLPs will leave post-acquisition — forcing them to recruit replacements in a shortage market — they discount the price to compensate.

Multi-Discipline Practices: OT and SLP Together

Many SLP practices operate alongside occupational therapy (OT) services, and this combination often enhances valuation. Pediatric patients frequently need both SLP and occupational therapy services — the child diagnosed with autism who receives speech therapy three times per week often receives OT twice per week as well. A practice that can serve both needs under one roof captures more revenue per patient and creates a more compelling value proposition for referral sources.

PE-backed therapy platform companies — the most active and highest-paying buyers in this space — specifically target multi-discipline practices because the cross-selling opportunity is proven. If you operate a combined SLP/OT practice, position the co-located service model as a deliberate strategy rather than an accident of history. Show buyers the percentage of patients who receive both services and the incremental revenue per patient.

Adding physical therapy to create a full pediatric rehabilitation platform (SLP + OT + PT) pushes you firmly into institutional buyer territory. These three-discipline practices with $3M+ revenue and strong clinical leadership are rare enough that they attract competitive bidding from multiple PE-backed platforms.

The Bottom Line

Speech therapy practice valuation is driven by a clear hierarchy: clinical staff retention first, patient demographics second, contract mix third, and operational infrastructure fourth. The practices commanding the best multiples have built teams of retained SLP-CCCs, serve a predominantly pediatric population with long-duration therapeutic relationships, diversified revenue across private insurance, EI contracts, and school districts, and developed telepractice capabilities that enable scalable growth.

If you're building toward an exit, the single highest-ROI investment is hiring and retaining strong clinicians. In a shortage market, the practice that has solved the talent problem has solved the business problem — and buyers will pay accordingly. Start building your team 2-3 years before your target exit date, and you'll position yourself for the premium end of the valuation range that this growing market can deliver.